(2S,3R,4R,4aR,6aR,6bR,8aS,12aS,14aR,14bR)-8a-[(2S,3R,4R,5R,6S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4R,5R)-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]oxy-4-hydroxy-6-methyloxan-2-yl]oxycarbonyl-2-hydroxy-6b-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

Details

Top
Internal ID 2626b58d-b551-44ac-8bd2-38f58c896e77
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name (2S,3R,4R,4aR,6aR,6bR,8aS,12aS,14aR,14bR)-8a-[(2S,3R,4R,5R,6S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4R,5R)-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]oxy-4-hydroxy-6-methyloxan-2-yl]oxycarbonyl-2-hydroxy-6b-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(C(C(OC2OC(=O)C34CCC(CC3C5=CCC6C(C5(CC4)CO)(CCC7C6(CC(C(C7(C)C(=O)O)OC8C(C(C(C(O8)CO)O)O)O)O)C)C)(C)C)C)OC(=O)C=CC9=CC(=C(C=C9)OC)OC)O)O)O)OC1C(C(C(CO1)OC1C(C(C(C(O1)CO)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@H]2OC(=O)[C@@]34CC[C@@]5(C(=CC[C@H]6[C@]5(CC[C@@H]7[C@@]6(C[C@@H]([C@@H]([C@]7(C)C(=O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)C)C)[C@@H]3CC(CC4)(C)C)CO)C)OC(=O)/C=C/C9=CC(=C(C=C9)OC)OC)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)O
InChI InChI=1S/C70H104O32/c1-29-54(99-58-49(82)45(78)39(27-92-58)97-60-50(83)46(79)43(76)37(25-71)95-60)48(81)52(85)59(93-29)100-56-53(86)55(98-42(75)15-11-31-10-13-35(90-8)36(22-31)91-9)30(2)94-62(56)102-64(89)69-19-18-65(3,4)23-33(69)32-12-14-40-66(5)24-34(74)57(101-61-51(84)47(80)44(77)38(26-72)96-61)68(7,63(87)88)41(66)16-17-67(40,6)70(32,28-73)21-20-69/h10-13,15,22,29-30,33-34,37-41,43-62,71-74,76-86H,14,16-21,23-28H2,1-9H3,(H,87,88)/b15-11+/t29-,30-,33-,34-,37+,38+,39+,40+,41+,43+,44+,45-,46-,47-,48-,49+,50+,51+,52+,53+,54-,55-,56+,57-,58-,59-,60-,61-,62-,66+,67+,68+,69-,70-/m0/s1
InChI Key MNXFXXWQAAMVMW-BNXHROHXSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C70H104O32
Molecular Weight 1457.60 g/mol
Exact Mass 1456.6510711 g/mol
Topological Polar Surface Area (TPSA) 495.00 Ų
XlogP -0.70
Atomic LogP (AlogP) -2.23
H-Bond Acceptor 31
H-Bond Donor 16
Rotatable Bonds 19

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,3R,4R,4aR,6aR,6bR,8aS,12aS,14aR,14bR)-8a-[(2S,3R,4R,5R,6S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4R,5R)-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]oxy-4-hydroxy-6-methyloxan-2-yl]oxycarbonyl-2-hydroxy-6b-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8680 86.80%
Caco-2 - 0.8586 85.86%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability - 0.8000 80.00%
Subcellular localzation Mitochondria 0.7598 75.98%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8000 80.00%
OATP1B3 inhibitior - 0.2595 25.95%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior + 0.9594 95.94%
P-glycoprotein inhibitior + 0.7425 74.25%
P-glycoprotein substrate + 0.7421 74.21%
CYP3A4 substrate + 0.7485 74.85%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8706 87.06%
CYP3A4 inhibition - 0.7405 74.05%
CYP2C9 inhibition - 0.8191 81.91%
CYP2C19 inhibition - 0.8017 80.17%
CYP2D6 inhibition - 0.9173 91.73%
CYP1A2 inhibition - 0.7097 70.97%
CYP2C8 inhibition + 0.8474 84.74%
CYP inhibitory promiscuity - 0.9547 95.47%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.6274 62.74%
Eye corrosion - 0.9892 98.92%
Eye irritation - 0.8960 89.60%
Skin irritation - 0.7231 72.31%
Skin corrosion - 0.9432 94.32%
Ames mutagenesis - 0.7200 72.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7546 75.46%
Micronuclear - 0.7400 74.00%
Hepatotoxicity - 0.7466 74.66%
skin sensitisation - 0.8834 88.34%
Respiratory toxicity + 0.6111 61.11%
Reproductive toxicity + 0.9333 93.33%
Mitochondrial toxicity - 0.5625 56.25%
Nephrotoxicity - 0.9288 92.88%
Acute Oral Toxicity (c) III 0.5612 56.12%
Estrogen receptor binding + 0.5622 56.22%
Androgen receptor binding + 0.7638 76.38%
Thyroid receptor binding + 0.7466 74.66%
Glucocorticoid receptor binding + 0.8193 81.93%
Aromatase binding + 0.7492 74.92%
PPAR gamma + 0.8177 81.77%
Honey bee toxicity - 0.6229 62.29%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.5300 53.00%
Fish aquatic toxicity + 0.9815 98.15%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.79% 91.11%
CHEMBL1293249 Q13887 Kruppel-like factor 5 98.92% 86.33%
CHEMBL4302 P08183 P-glycoprotein 1 98.79% 92.98%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.33% 96.09%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 96.10% 96.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 95.65% 97.36%
CHEMBL1806 P11388 DNA topoisomerase II alpha 94.76% 89.00%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 94.41% 95.17%
CHEMBL221 P23219 Cyclooxygenase-1 93.95% 90.17%
CHEMBL241 Q14432 Phosphodiesterase 3A 93.44% 92.94%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.84% 95.56%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.16% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.08% 97.09%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 89.72% 96.21%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 89.40% 91.07%
CHEMBL225 P28335 Serotonin 2c (5-HT2c) receptor 89.16% 89.62%
CHEMBL5028 O14672 ADAM10 87.51% 97.50%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 86.70% 97.33%
CHEMBL5608 Q16288 NT-3 growth factor receptor 86.05% 95.89%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 85.36% 95.89%
CHEMBL2581 P07339 Cathepsin D 85.12% 98.95%
CHEMBL1255126 O15151 Protein Mdm4 84.47% 90.20%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.44% 100.00%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 83.44% 93.00%
CHEMBL4829 O00763 Acetyl-CoA carboxylase 2 83.17% 98.00%
CHEMBL340 P08684 Cytochrome P450 3A4 83.06% 91.19%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.62% 99.17%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 82.31% 95.83%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 81.94% 92.62%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 81.81% 97.14%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 80.30% 86.92%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Polygala senega

Cross-Links

Top
PubChem 11968932
NPASS NPC131437